Medgenics Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Medgenics, Inc. (MDGN) Widens Q2 Loss to 21c/Share
July 16, 2014 8:43 AM EDTMedgenics, Inc. (NYSE: MDGN) reported Q2 EPS of ($0.21), versus ($0.11) reported last year.
For earnings history and earnings-related data on Medgenics, Inc. (MDGN) click here.
... More